BioSpace News Archive

Business

Oliver Frank Appointed Vice President Phonak Marketing

Phonak, a leading global provider of life-changing hearing solutions, announces that Oliver Frank will be taking up the position as Vice President Phonak Marketing effective December 1, 2022.

October 12, 2022
·
1 min read
Drug Development

Kronos Bio to Present Preclinical Data for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers, in Pediatric Cancer Models in Poster Presentation at EORTC-NCI-AACR 2022

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, announced that it will present preclinical data in a poster at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.

October 12, 2022
·
4 min read
Business

Capstan Therapeutics Announces Appointment of Athena Countouriotis, M.D., as Board Chair and Strengthens Leadership Team with Key Appointment

Capstan Therapeutics, Inc. announced the appointment of experienced biotechnology leader Athena Countouriotis, M.D., as Board Chair and Michael Rosenzweig, DVM, Ph.D., as Executive Vice President, Portfolio Strategy and Product Development.

October 12, 2022
·
4 min read
Business

NanoString to Release Third Quarter 2022 Operating Results and Host Conference Call on Monday, November 7, 2022

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will report third quarter 2022 operating results after the close of the market on Monday, November 7, 2022.

October 12, 2022
·
2 min read
Pharm Country

Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Rocket Pharmaceuticals, Inc. announces data presentations at the 29th Annual Congress of the European Society of Gene & Cell Therapy in Edinburgh, United Kingdom, taking place October 11-14, 2022.

October 12, 2022
·
12 min read
Pharm Country

EYLEA® (aflibercept) Injection sBLA for Treatment of Retinopathy of Prematurity (ROP) Accepted for FDA Priority Review

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for EYLEA ® (aflibercept) Injection to treat Retinopathy of Prematurity (ROP) in preterm infants.

October 12, 2022
·
13 min read
Pharm Country

CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

CytoSorbents Corporation announced the presentation of exciting new data on the use of CytoSorb® in various cardiac surgery indications at the 36th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting last week in Milan, Italy.

October 12, 2022
·
15 min read
Biotech Bay

Avail Medsystems to Participate at Upcoming Industry and Investor Conferences

Avail, the digital hub of the operating room enabling the medical technology (MedTech) and healthcare industries to work smarter to advance patient care, today announced that Avail’s senior management team will present at the following upcoming conferences.

October 12, 2022
·
2 min read
Pharm Country

Elysium Health™ Announces Positive Results on Its Product Basis™ Published in Hepatology

Elysium Health, Inc.™, a leading life sciences company focused on aging research, today announced that the detailed results from its clinical trial on Basis™ (NRPT) in people with non-alcoholic fatty liver disease (NAFLD) were published in Hepatology.

October 12, 2022
·
4 min read
BioCapital

Alexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRIS® (ravulizumab-cwvz) efficacy data at ECTRIMS 2022

Alexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRIS ® (ravulizumab-cwvz) efficacy data at ECTRIMS 2022.

October 12, 2022
·
11 min read